文献速递呼吸危重症与机械通气

经鼻高流量氧疗调节经口气管插管患者呼吸困难

Nasal High Flow to Modulate Dyspnea in Orally Intubated Patients.
PubMed 文献 · Am J Respir Crit Care Med · 2025-01-01

结果显示NHF可降低呼吸困难NRS评分和P0.1,但不改变MV-RDOS评分、食管压、呼吸肌EMG及气体交换。

要点

  • NHF可降低经口气管插管患者呼吸困难NRS评分
  • NHF降低P0.1提示呼吸驱动下降,但不改变吸气做功
  • NHF对MV-RDOS评分、食管压及气体交换无显著影响

核心结论

  • 经口气管插管患者中,NHF与较低的呼吸困难和较低的呼吸驱动相关,但不影响吸气做功。

研究设计与样本

  • 比较压力支持通气下NHF流量0、30、50、60 L/min(后三者随机顺序)及SBT下NHF 0和50 L/min(随机)两种序列。
  • NHF参数为FiO2 21%、温度31°C。

主要发现

  • 压力支持通气下,NHF 0 L/min时呼吸困难NRS评分为5(范围4-6),NHF 30 L/min和50 L/min时分别为3(范围2-6)和3(范围2-5)(P<0.05)。
  • 压力支持通气下,MV-RDOS评分、P0.1、食管压、呼吸肌EMG及气体交换无变化。
  • SBT期间,NHF 50 L/min时呼吸困难NRS评分和P0.1低于NHF 0 L/min(P<0.01和P=0.04)。
  • SBT期间,NHF 50 L/min时MV-RDOS评分、食管压和呼吸肌EMG与NHF 0 L/min相比无变化。

临床怎么用

  • 对经口气管插管压力支持通气下存在呼吸困难的患者,可考虑应用NHF以降低呼吸困难和呼吸驱动。
  • NHF降低呼吸困难NRS评分和P0.1的效应需结合患者个体情况评估。

局限性

  • NHF参数固定为FiO2 21%、温度31°C,其他参数设置下的效果未明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: High-flow therapy reduces dyspnea in acute respiratory failure, but the underlying mechanisms are not fully elucidated. Objectives: To compare dyspnea, we measured airway occlusion pressure (P0.1) and inspiratory work with and without nasal high flow (NHF; FiO2, 21%; temperature, 31°C) in intubated patients under pressure support ventilation and during a spontaneous breathing trial (SBT). Methods: Dyspnea (determined using numerical rating scale [NRS] and Mechanical Ventilation - Respiratory Distress Observational Scale [MV-RDOS] scores), P0.1, esophageal pressure, respiratory muscle EMG, and arterial blood gas were compared in intubated patients on pressure support ventilation presenting a dyspnea-NRS score higher than 3 during two sequences: 1) pressure support ventilation with NHF at 0 L/min followed by 30, 50, and 60 L/min (the last three were randomized) and 2) an SBT with NHF at 0 and 50 L/min (randomized). Measurements and Main Results: Twenty patients were included. During pressure support ventilation, as compared with a dyspnea-NRS score of 5 (range = 4-6) at an NHF of 0 L/min, dyspnea-NRS scores were 3 (range = 2-6) and 3 (range = 2-5) at NHFs of 30 L/min and 50 L/min, respectively (P < 0.05). However, there was no change in MV-RDOS score, P0.1, esophageal pressure, respiratory muscle EMG, and gas exchange. During the SBT, at an NHF of 50 L/min, dyspnea-NRS score and P0.1 were lower than during the SBT at an NHF of 0 L/min (P < 0.01 and P = 0.04, respectively), whereas MV-RDOS score, esophageal pressure, and respiratory muscle EMG did not change as compared with findings in an SBT with an NHF of 0 L/min. Conclusions: In orally intubated patients, NHF was associated with lower dyspnea and lower respiratory drive without affecting the inspiratory work.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Le Stang V, Graverot M, Kimmoun A, et al. Nasal High Flow to Modulate Dyspnea in Orally Intubated Patients. Am J Respir Crit Care Med. 2025. PMID: 39680951. doi:10.1164/rccm.202405-1057OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。